After the GEMINI-ACS-1 trial
Küçük Resim Yok
Tarih
2017
Yazarlar
Yilmaz, Mehmet Birhan
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
TURKISH SOC CARDIOLOGY
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
The GEMINI-ACS-1 trial has recently been published. It was designed to test whether low dose rivaroxaban as an antithrombotic agent is as safe as aspirin in patients with acute coronary syndromes (ACS). The trial is important to set light to future of ACS management.
Açıklama
Anahtar Kelimeler
Kaynak
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
WoS Q Değeri
N/A
Scopus Q Değeri
Q4
Cilt
45
